Why is IQE stock climbing today?

IQE reported H1 2026 revenue of £64.6 million, up 43% year-on-year, and adjusted EBITDA of £6.0 million versus a £0.4 million loss a year earlier. Photonics revenue rose 45% to £38.5 million on AI infrastructure and data-centre demand, while wireless revenue grew 40% to £26.0 million. Following an £81 million fundraise, IQE ended the period debt-free with £41.6 million in cash and raised its full-year revenue-growth outlook to above 30%; shares gained 0.9% to 47.89p despite a weaker FTSE 100 backdrop.

Analysis

The investable question is whether IQE can convert an early operating-leverage inflection into durable free cash flow rather than merely report an EBITDA improvement aided by higher fab utilization. Photonics should carry higher strategic value than legacy wireless exposure, but the valuation re-rating will depend on gross-margin progression, customer concentration and evidence that capacity additions are funded by customers rather than dilutive equity. The strategic relationship with MTSI is more important as a potential qualification and volume signal than as a direct earnings contributor; it also raises the probability of deeper commercial integration or, eventually, corporate activity.

Near term, thin AIM liquidity makes a technical follow-through above the recent intraday high more informative than the modest initial reaction. Over the next 1-3 months, order-book visibility, H2 margin guidance and any disclosure on AI/datacenter customer ramps are the likely catalysts; a revenue beat without incremental EBITDA conversion would undermine the thesis. Over 6-18 months, higher rates are a secondary risk because long-duration AI supply-chain valuations can compress, but IQE's more immediate vulnerability is a pause in optical-component inventory replenishment or a single-customer qualification delay.

Consensus may be treating the fundraise as an unqualified balance-sheet positive. It removes financing stress, but it also means per-share upside now requires a materially faster earnings ramp to offset dilution; management's forward claims remain unverified until cash generation appears. MTSI is not a clean sympathy long: any benefit from a more secure epiwafer supply chain is likely immaterial relative to its broader RF, optical and defense end-market drivers.

The setup is attractive only as a confirmation trade, not a chase on optimistic sell-side targets. A sustained break above 50.4p could open a retest of the low-60p area, while failure to hold the mid-40p range after the next trading update would indicate that the market doubts the quality or durability of the inflection.

Key Decisions for Investors

• Initiate a small long IQE only on a daily close above 50.4p with normalised volume; target 61-63p over 1-3 months and 70-73p over 6-12 months. Use a 43p stop or exit if the next update fails to reaffirm full-year growth and EBITDA progression; this offers roughly 2.5-3x upside/downside from a confirmed entry.
• Treat IQE as a catalyst watch until management discloses operating cash flow, capex requirements, gross margin and customer concentration. Do not underwrite a full position from adjusted EBITDA alone; a weak cash-conversion print would be thesis-falsifying even if revenue remains strong.
• Do not add a directional MTSI position solely on this development. Instead, monitor for explicit supply agreements, purchase commitments or incremental ownership disclosures; those would make MTSI a potential low-beta beneficiary, whereas absent such evidence the linkage is too small to drive estimates.
• For existing IQE holders, trim 25-33% if the shares approach the low-60p area before a further fundamental update. That zone likely prices in much of the near-term rerating, while an H2 customer-ramp miss could reverse the move quickly in an illiquid AIM name.